image
Rallybio Corporation RLYB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.284
6.04 %
$ 11.8 M
Market Cap
-0.2
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
396.41%
EBIT Estimate
55.39%
Net Income Estimate
54.47%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Rallybio Corporation
image
RLYB has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart RLYB

image
$400.0m$400.0m$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RLYB

image
$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RLYB

image
$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)20232023202420242025202520262026202720272028202820292029